Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting, 26970 [E6-7020]
Download as PDF
<![CDATA[
26970
Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices
to better describe geographic variation
in cancer incidence throughout the
country and provide incidence data on
minority populations and rare cancers
to further plan and evaluate state and
national cancer control and prevention
efforts.
Therefore, CDCs, NCCDPHP, Division
of Cancer Prevention and Control
proposes to continue to aggregate
existing cancer incidence data from
year for which the cancer registry
collected data with the assistance of
NPCR funds (e.g., 1995) through to 12
months past the close of the most recent
diagnosis year (e.g., 2004).
NCCPHP is requesting a 3-year
clearance for this project. There are no
costs to respondents except their time to
participate in the survey.
states funded by the National Program
of Cancer Registries into a national
surveillance system.
These data are already collected and
aggregated at the state level. Thus the
additional burden for the states is small.
Funded states are asked to continue to
report cancer incidence data to CDC on
an annual basis. Each state is requested
to report a cumulative file containing
incidence data from the first diagnosis
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
resondent
Number of
respondents
Respondents
Average
burden per response
(in hours)
Total burden
hours
States, Territories, and the District of Columbia (Cancer Registries) .............
63
1
2
126
Total ..........................................................................................................
........................
........................
........................
126
Dated: May 3, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7019 Filed 5–8–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Heritable
Disorders and Genetic Diseases in
Newborns and Children; Notice of
Meeting
mstockstill on PROD1PC68 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Heritable
Disorders and Genetic Diseases in Newborns
and Children (ACHDGDNC).
Dates and Times: June 5, 2006, 9 a.m. to
5 p.m. June 6, 2006, 8:30 a.m. to 3 p.m.
Place: Four Points Sheraton Downtown,
Franklin AB Room, 1201 K Street, NW.,
Washington, DC 20005.
Status: The meeting will be open to the
public with attendance limited to space
availability.
Purpose: The Advisory Committee
provides advice and recommendations
concerning the grants and projects authorized
under the Heritable Disorders Program and
technical information to develop policies and
priorities for this program. The Heritable
Disorders Program was established to
enhance the ability of State and local health
agencies to provide for newborn and child
screening, counseling and health care
services for newborns and children having or
at risk for heritable disorders. The Committee
was established specifically to advise and
guide the Secretary regarding the most
appropriate application of universal newborn
VerDate Aug<31>2005
15:42 May 08, 2006
Jkt 208001
screening tests, technologies, policies,
guidelines and programs for effectively
reducing morbidity and mortality in
newborns and children having or at risk for
heritable disorders.
Agenda: The meeting will be devoted to
the decision making process for candidate
conditions on the Newborn Screening Panel
as well as the continued work and reports by
the Committee’s subcommittees on laboratory
standards and procedures, follow-up
treatment, education and training.
Proposed agenda items are subject to
change.
Time will be provided each day for public
comment. Individuals who wish to provide
public comment or who plan to attend the
meeting and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should notify
the ACHDGDNC Executive Secretary,
Michele A. Lloyd-Puryear, M.D., Ph.D.
(contact information provided below).
Contact Person: Anyone interested in
obtaining a roster of members or other
relevant information should write or contact
Michele A. Lloyd-Puryear, M.D., Ph.D.,
Maternal and Child Health Bureau, Health
Resources and Services Administration,
Room 18A–19, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland 20857,
Telephone (301) 443–1080. Information on
the Advisory Committee is available at https://
mchb.hrsa.gov/programs/genetics/committee.
Dated: May 3, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and
Coordination.
[FR Doc. E6–7020 Filed 5–8–06; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Tribal Management Grant Program
Announcement Type: New
Discretionary Funding Cycle for Fiscal
Year 2007.
Funding Announcement Number:
HHS–2007–IHS–TMP–0001.
Catalog of Federal Domestic
Assistance Number: 93.228.
Key Dates: Training: Application
Requirements Session: May 10–11 and
June 14–15, 2006; Grantwriting Session:
May 22–26, 2006; Application Deadline
Date: August 4, 2006; Review Date:
October 2–6, 2006; Application
Notification: November 13, 2006;
Earliest Anticipated Start Date: January
1, 2007.
I. Funding Opportunity Description
The Indian Health Service (IHS)
announces competitive grant
applications for the Tribal Management
Grant (TMG) Program. This program is
authorized under section 103(b)(2) and
section 103(e) of the Indian SelfDetermination and Education
Assistance Act, Public Law 93–638, as
amended. The TMG Program is
described at 93.228 in the Catalog of
Federal Domestic Assistance.
The TMG program is a national
competitive discretionary grant program
pursuant to 45 CFR part 75 and 45 CFR
part 92 established to assist Federallyrecognized Tribes and Triballysanctioned Tribal organizations in
assuming all or part of existing IHS
programs, services, functions, and
activities (PSFA) through a Title I
contract and to assist established Title I
contractors and Title V compactors to
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 71, Number 89 (Tuesday, May 9, 2006)]
[Notices]
[Page 26970]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7020]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Heritable Disorders and Genetic Diseases in
Newborns and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Heritable Disorders and Genetic
Diseases in Newborns and Children (ACHDGDNC).
Dates and Times: June 5, 2006, 9 a.m. to 5 p.m. June 6, 2006,
8:30 a.m. to 3 p.m.
Place: Four Points Sheraton Downtown, Franklin AB Room, 1201 K
Street, NW., Washington, DC 20005.
Status: The meeting will be open to the public with attendance
limited to space availability.
Purpose: The Advisory Committee provides advice and
recommendations concerning the grants and projects authorized under
the Heritable Disorders Program and technical information to develop
policies and priorities for this program. The Heritable Disorders
Program was established to enhance the ability of State and local
health agencies to provide for newborn and child screening,
counseling and health care services for newborns and children having
or at risk for heritable disorders. The Committee was established
specifically to advise and guide the Secretary regarding the most
appropriate application of universal newborn screening tests,
technologies, policies, guidelines and programs for effectively
reducing morbidity and mortality in newborns and children having or
at risk for heritable disorders.
Agenda: The meeting will be devoted to the decision making
process for candidate conditions on the Newborn Screening Panel as
well as the continued work and reports by the Committee's
subcommittees on laboratory standards and procedures, follow-up
treatment, education and training.
Proposed agenda items are subject to change.
Time will be provided each day for public comment. Individuals
who wish to provide public comment or who plan to attend the meeting
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the ACHDGDNC
Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact
information provided below).
Contact Person: Anyone interested in obtaining a roster of
members or other relevant information should write or contact
Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child Health
Bureau, Health Resources and Services Administration, Room 18A-19,
Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857,
Telephone (301) 443-1080. Information on the Advisory Committee is
available at https://mchb.hrsa.gov/programs/genetics/committee.
Dated: May 3, 2006.
Tina M. Cheatham,
Director, Division of Policy Review and Coordination.
[FR Doc. E6-7020 Filed 5-8-06; 8:45 am]
BILLING CODE 4165-15-P
